GSA Capital Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,330
Closed -$430K 1899
2019
Q3
$430K Sell
4,330
-9,821
-69% -$933K 0.06% 644
2019
Q2
$1.31M Buy
+14,151
New +$1.34M 0.15% 133
2019
Q1
Sell
-16,500
Closed -$1.06M 1863
2018
Q4
$1.06M Sell
16,500
-9,260
-36% -$684K 0.12% 196
2018
Q3
$2.31M Buy
25,760
+6,944
+37% +$614K 0.13% 181
2018
Q2
$1.49M Sell
18,816
-6,247
-25% -$519K 0.07% 453
2018
Q1
$2.24M Sell
25,063
-9,767
-28% -$938K 0.12% 225
2017
Q4
$3.63M Buy
34,830
+25,433
+271% +$2.87M 0.22% 46
2017
Q3
$1.37M Buy
+9,397
New +$1.28M 0.09% 325
2017
Q2
Sell
-12,715
Closed -$1.58M 2156
2017
Q1
$1.58M Sell
12,715
-483
-4% -$57.8K 0.08% 374
2016
Q4
$1.53M Sell
13,198
-23,007
-64% -$2.56M 0.09% 322
2016
Q3
$3.79M Buy
36,205
+20,156
+126% +$2.18M 0.2% 55
2016
Q2
$1.58M Sell
16,049
-1,087
-6% -$112K 0.09% 352
2016
Q1
$1.72M Sell
17,136
-7,224
-30% -$744K 0.11% 250
2015
Q4
$2.92M Sell
24,360
-130,374
-84% -$15.1M 0.14% 133
2015
Q3
$16.7M Buy
154,734
+131,027
+553% +$16.3M 0.82% 2
2015
Q2
$2.74M Sell
23,707
-26,395
-53% -$3.02M 0.11% 200
2015
Q1
$5.78M Buy
50,102
+37,787
+307% +$4.52M 0.23% 35
2014
Q4
$1.38M Sell
12,315
-3,657
-23% -$386K 0.1% 288
2014
Q3
$1.51M Buy
+15,972
New +$1.44M 0.08% 291
2014
Q2
Sell
-99,942
Closed -$6.98M 2124
2014
Q1
$6.98M Buy
99,942
+89,856
+891% +$7.12M 0.5% 19
2013
Q4
$852K Sell
10,086
-11,556
-53% -$914K 0.07% 466
2013
Q3
$1.67M Buy
21,642
+1,538
+8% +$108K 0.13% 155
2013
Q2
$1.18M Buy
+20,104
New +$1.21M 0.14% 173

Other funds holding CELG

GSA Capital Partners's CELG Position: Q4 2019 in Review

GSA Capital Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,330 shares — an estimated $430K sold.

GSA Capital Partners first reported a position in CELG in Q2 2013 and held it in 23 quarters. The position peaked at $16.7M in Q3 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • GSA Capital Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • GSA Capital Partners sold 4,330 Celgene Corp shares in Q4 2019, an estimated $430K.
  • GSA Capital Partners first reported a position in Celgene Corp in Q2 2013 and held it in 23 quarters.
  • GSA Capital Partners's Celgene Corp position peaked at $16.7M in Q3 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on GSA Capital Partners's 13F filing for Q4 2019, filed 12 Feb 2020.